The therapeutic potential of PI3K/Akt/mTOR inhibitors in breast cancer: rational and progress

A Bahrami, M Khazaei, S Shahidsales… - Journal of cellular …, 2018 - Wiley Online Library
Breast cancer (BC) is the most commonly diagnosed cancer in women. The PI3K/AKT/mTOR
pathway is among the most frequently dysregulated pathways in patients with BC. The …
被引用次数：91 相关文章

The Therapeutic Potential of PI3K/Akt/mTOR Inhibitors in Breast Cancer: Rational and Progress.

A Bahrami, M Khazaei, S Shahidsales… - Journal of Cellular …, 2017 - europepmc.org
The Therapeutic Potential of PI3K/Akt/mTOR Inhibitors in Breast Cancer: Rational and Progress.
- Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About …

The Therapeutic Potential of PI3K/Akt/mTOR Inhibitors in Breast Cancer: Rational and Progress

A Bahrami, M Khazaei… - Journal of cellular …, 2018 - pubmed.ncbi.nlm.nih.gov
Breast cancer (BC) is the most commonly diagnosed cancer in women. The PI3K/AKT/mTOR
pathway is among the most frequently dysregulated pathways in patients with BC. The …